SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001011034-17-000023
Filing Date
2017-03-29
Accepted
2017-03-29 17:23:04
Documents
6
Period of Report
2017-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 VITRO DIAGNOSTICS, INC. vitro_8k.htm 8-K 27094
2 MEMORANDUM OF UNDERSTANDING vitro_10ez1.htm EX-10.1 9643
3 STEM CELL LAB DEVELOPMENT AGREEMENT vitro_10ez2.htm EX-10.2 54949
4 CONSULTING AGREEMENT vitro_10ez3.htm EX-10.3 17474
5 PROMISSORY NOTE vitro_99ez1.htm EX-99.1 15792
6 PRESS RELEASE vitro_99ez2.htm EX-99.2 14561
  Complete submission text file 0001011034-17-000023.txt   141013
Mailing Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403
Business Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403 (720) 859-4120
VITRO DIAGNOSTICS INC (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-17378 | Film No.: 17723039
SIC: 2836 Biological Products, (No Diagnostic Substances)